Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose
Ended Project Grant Awarded Last action
- Award ID
- R43DA050397
- Recipient
-
BDH Pharma LLC UEI DWZ7Q4JXJK78
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $338,935
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $55,000 | |
| Amendment | $0 | |
| Original award | $283,935 |
Quick answers
Who received award R43DA050397?
R43DA050397 was awarded to BDH Pharma LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2019.
How much is award R43DA050397 worth?
$338,935 has been obligated on R43DA050397.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award